The Canadian marijuana stocks on our list have managed sustained highs despite a ‘downer’ of a year so far for the market leaders
SmallCapPower | September 8, 2017: Today we present three Canadian marijuana stocks that have delivered the strongest stock-price appreciation so far in 2017. The market caps of the selected stocks range between $136 million and $311 million. An interesting observation is that the top three marijuana Canadian stocks in terms of market capitalization – Canopy Growth Corporation, Aurora Cannabis Inc., and Aphria Inc. – have performed poorly, delivering negative returns YTD in 2017.
Cannabis Wheaton Income Corp. (TSXV: CBW)
Cannabis Wheaton Income Corp is an investment company that seeks to provide investor returns through streams and capital appreciation in the Canadian cannabis industry. The Company provides funding for facility expansions, operations and initial construction in exchange for minority equity interests and a portion of the cultivation production.
Newstrike Resources Ltd. (TSXV: HIP)
Newstrike Resources is a licensed producer of medical cannabis through its wholly-owned subsidiary Hemisphere Pharmaceuticals. Hemisphere Pharmaceuticals received its cultivation license on December 19, 2016, and is based in Brantford, Ontario. Newstrike intends to develop a diverse network of high-quality cannabis brands that addresses the needs of medical clients and eventually, as the law allows, adult consumers.
Cronos Group Inc. (TSXV: MJN)
Cronos Group operates two licensed producers, Peace Naturals Project Inc. and In The Zone Produce Ltd. The Company also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals.
Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: